产品编号 :
Cas No. :
CAS No. |
347155-76-4 |
|---|---|
中文名称 |
Ki11502 |
英文名称 |
Ki11502 |
别名 |
1-(4-(6,7-Dimethoxy-quinolin-4-yloxy)-phenyl)-3-(2-methyl-benzoyl)-thiourea | GTPL6021 | CHEBI:133397 | Ki11502 | Ki-11502 | PDGFR tyrosine kinase inhibitor V | N-{4-[(6,7-Dimethoxy-4-quinolyl)oxy]-phenyl}-N'-(2-methylbenzoyl)thiourea | UNII-LEB9DP4H6C | |
标准英文名 |
N-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamothioyl)-2-methylbenzamide |
分子式 |
C26H23N3O4S |
分子量 |
473.55 |
精确分子量 |
473.14 |
SMILES |
O=C(NC(NC1=CC=C(OC2=CC=NC3=CC(OC)=C(OC)C=C23)C=C1)=S)C4=CC=CC=C4C |
标准SMILES |
CC1=CC=CC=C1C(=O)NC(=S)NC1C=CC(=CC=1)OC1=CC=NC2=CC(OC)=C(C=C12)OC |
用途 |
PDGFR Tyrosine Kinase Inhibitor V (Ki11502) is suitable for studying the role of PDGF in vascular diseases, particularly the role of proteoglycans in atherosclerosis; it selectively inhibits PDGFβ/α receptor activity (IC50 < 10 nM), suppresses PDGFβ receptor phosphorylation, proliferation, and proteoglycan synthesis in human vascular smooth muscle cells, and induces apoptosis with significant antiproliferative effects against specific leukemia subpopulations, including those harboring Imatinib-resistant mutations. |
InChIKey |
ZXGIBSBJQLLUEE-UHFFFAOYSA-N |
|
|
评论 |
|---|